- Case-Based Modules
- Initial Evaluation
- Dermatologic Manifestations
- Oral Manifestations
- OIs: Prophylaxis
- OIs: Treatment
- Antiretroviral Rx
- Antiretroviral Rx: Resistance
- Antiretroviral Rx: Adverse Effects
- Drug-Drug Interactions
- Postexposure Prophylaxis
- Perinatal Transmission
- Special Populations
- Prevention for Positives
- Challenging Unknowns
- Resource-Limited Settings
- Interactive Tutorials
- Routine HIV Screening
- Oraquick Advance Rapid HIV Test
- HIV Integration
- This program is funded through Health Resources and Services Administration, US Department of Health and Human Services.
Prevention for Positives
Question | Discussion | References | CME Credit
Case 2: Screening for High-risk Behavior
You answered:
 |
Although his diabetes control and response to antiviral medications should be addressed during this visit, screening for high-risk behavior related to HIV transmission should also ideally be performed during the initial clinic visit. |
|---|
This answer is correct. A complete screening for high-risk behavior should be performed at the initial clinic visit with every HIV-infected patient. More tailored risk screening should be performed at regular intervals thereafter.
Copyright © 2004-2013 University of Washington